Get the Stockscreener App
8.47
1.40%
-0.12
After Hours:
8.31
-0.16
-1.89%
Arcutis Biotherapeutics Inc Stock (ARQT) Forecast
The Arcutis Biotherapeutics Inc (ARQT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.81, representing a +74.82% increase from the current price of $8.47. The highest analyst price target is $22.27, and the lowest is $7.344.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ARQT Price Target
Average 12.63
(+49.15% Upside)
Is Arcutis Biotherapeutics Inc (ARQT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 36.55 | Neutral |
| STOCH(9,6) | 11.99 | Buy |
| STOCHRSI(14) | 0.3551 | Buy |
| MACD(12,26) | -0.3725 | Sell |
| ADX(14) | 24.72 | Neutral |
| William %R | -94.76 | Buy |
| CCI(14) | -89.55 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
9.248
Sell
|
9.2265
Sell
|
| MA20 |
10.14
Sell
|
9.6769
Sell
|
| MA50 |
10.12
Sell
|
9.2863
Sell
|
| MA100 |
7.0613
Buy
|
8.117
Buy
|
| MA200 |
6.4989
Buy
|
8.0819
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, ARQT could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on ARQT, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 36.55 indicates that ARQT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 11.99 indicates that ARQT is oversold. This indicates that ARQT price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0.3551 indicates that ARQT is oversold. This suggests that ARQT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.72 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -89.55 indicates that ARQT is still oversold but not to an extreme extent.
Long-term ARQT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Arcutis Biotherapeutics Inc financial reports and earnings history, Arcutis Biotherapeutics Inc (ARQT) stock could reach $2.9701 by 2030, $9.3013 by 2040 and $14.94 by 2050. See the projected annual prices until 2050 of the Arcutis Biotherapeutics Inc stock below:
- Arcutis Biotherapeutics Inc (ARQT) is expected to reach an average price of $15.37 in 2035, with a high prediction of $16.80 and a low estimate of $16.30. This indicates an $81.49% rise from the last recorded price of $8.47.
- Arcutis Biotherapeutics Inc (ARQT) stock is projected to chart a bullish course in 2040, with an average price target of $8.2267, representing an $-2.87% surge from its current level. The forecast ranges from a conservative $9.0908 to a sky-high $9.3013.
- Our analysts predict Arcutis Biotherapeutics Inc (ARQT) to jump 56.82% by 2045, soaring from $13.69 to an average price of $13.28, potentially reaching $13.64. While $13.69 is the low estimate, the potential upside is significant.
- Arcutis Biotherapeutics Inc (ARQT) stock is expected to climb by 2050, reaching an average of $14.26, a $68.36% jump from its current level. However, a wide range of estimates exists, with high and low targets of $14.94 and $13.51, respectively, highlighting the market's uncertainty.
Arcutis Biotherapeutics Inc Stock (ARQT) Year by Year Forecast
Arcutis Biotherapeutics Inc Stock (ARQT) Price Forecast for 2024
Our forecast for ARQT stock price in 2024 now indicates an average price target of $11.58 with a high forecast of $22.27 and a low forecast of $0.8889. The average prediction reflects an increase of +36.71% from the last recorded price of $8.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $16.22 | $7.344 | $22.27 | +91.47% |
| June, 2024 | $11.80 | $10.65 | $22.24 | +39.33% |
| July, 2024 | $9.2392 | $6.8592 | $12.94 | +9.08% |
| August, 2024 | $7.7733 | $6.3283 | $12.78 | -8.23% |
| September, 2024 | $7.0409 | $6.6368 | $15.10 | -16.87% |
| October, 2024 | $1.855 | $1.565 | $8.8144 | -78.10% |
| November, 2024 | $10.27 | $1.6185 | $10.71 | +21.24% |
| December, 2024 | $14.31 | $9.1061 | $16.83 | +68.91% |
Arcutis Biotherapeutics Inc Stock (ARQT) Price Forecast for 2025
Arcutis Biotherapeutics Inc Stock (ARQT) is expected to reach an average price of $14.13 in 2025, with a high prediction of $23.70 and a low estimate of $4.5648. This indicates an +66.86% rise from the last recorded price of $8.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $11.80 | $11.46 | $15.96 | +39.32% |
| February, 2025 | $21.42 | $9.3143 | $23.70 | +152.95% |
| March, 2025 | $13.78 | $12.95 | $21.96 | +62.72% |
| April, 2025 | $13.47 | $11.73 | $16.08 | +58.99% |
| May, 2025 | $11.99 | $11.03 | $22.54 | +41.57% |
| June, 2025 | $13.96 | $10.08 | $15.98 | +64.80% |
| July, 2025 | $13.39 | $11.11 | $14.64 | +58.11% |
| August, 2025 | $8.6799 | $7.9564 | $14.43 | +2.48% |
| September, 2025 | $9.214 | $5.8535 | $10.32 | +8.78% |
| October, 2025 | $11.83 | $7.5876 | $12.28 | +39.65% |
| November, 2025 | $9.7822 | $8.9023 | $13.74 | +15.49% |
| December, 2025 | $5.1898 | $4.5648 | $12.53 | -38.73% |
Arcutis Biotherapeutics Inc Stock (ARQT) Price Forecast for 2026
The predicted value for Arcutis Biotherapeutics Inc (ARQT) in 2026 is set at an average of $11.07. Estimates vary from a peak of $19.30 to a trough of $2.845, indicating an +30.74% surge from the present price of $8.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.8839 | $2.9739 | $6.0539 | -30.53% |
| February, 2026 | $6.518 | $5.228 | $12.03 | -23.05% |
| March, 2026 | $4.9456 | $2.845 | $6.8306 | -41.61% |
| April, 2026 | $6.5597 | $4.1977 | $8.7497 | -22.55% |
| May, 2026 | $9.3238 | $4.8732 | $9.7438 | +10.08% |
| June, 2026 | $10.62 | $9.4173 | $12.45 | +25.40% |
| July, 2026 | $11.72 | $6.6484 | $13.33 | +38.32% |
| August, 2026 | $11.70 | $9.7296 | $14.06 | +38.17% |
| September, 2026 | $15.59 | $11.27 | $17.52 | +84.03% |
| October, 2026 | $16.81 | $11.05 | $17.39 | +98.48% |
| November, 2026 | $12.48 | $12.25 | $19.30 | +47.33% |
| December, 2026 | $11.48 | $9.1324 | $14.01 | +35.57% |
Arcutis Biotherapeutics Inc Stock (ARQT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Arcutis Biotherapeutics Inc (ARQT) is $7.6772, with a high forecast of $12.97 and a low forecast of $2.3868. This indicates an -9.36% decrease from the last price of $8.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $10.32 | $8.7535 | $12.41 | +21.81% |
| February, 2027 | $10.90 | $9.7741 | $12.97 | +28.70% |
| March, 2027 | $7.5988 | $6.6688 | $11.27 | -10.29% |
| April, 2027 | $9.8329 | $6.3293 | $9.9429 | +16.09% |
| May, 2027 | $10.93 | $9.1655 | $11.39 | +29.05% |
| June, 2027 | $6.3446 | $6.1246 | $11.75 | -25.09% |
| July, 2027 | $6.5786 | $4.4516 | $7.1381 | -22.33% |
| August, 2027 | $4.9963 | $4.6963 | $10.05 | -41.01% |
| September, 2027 | $3.4103 | $2.3868 | $5.4998 | -59.74% |
| October, 2027 | $5.0344 | $3.3239 | $6.6674 | -40.56% |
| November, 2027 | $6.782 | $4.2679 | $7.115 | -19.93% |
| December, 2027 | $3.9061 | $2.5611 | $6.9291 | -53.88% |
Arcutis Biotherapeutics Inc Stock (ARQT) Price Forecast for 2028
In 2028, Arcutis Biotherapeutics Inc (ARQT) is projected to reach an average price of $7.0417, with a high projection of $14.00 and a low estimate of $0.0834. This indicates an -16.86% fall from the last price of $8.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.9137 | $1.8137 | $5.5817 | -77.41% |
| February, 2028 | $0.7072 | $0.0907 | $3.0273 | -91.65% |
| March, 2028 | $0.9731 | $0.8016 | $0.5751 | -88.51% |
| April, 2028 | $0.594 | $0.824 | $0.584 | -92.99% |
| May, 2028 | $11.86 | $0.0834 | $14.00 | +40.06% |
| June, 2028 | $9.4148 | $11.66 | $10.38 | +11.15% |
| July, 2028 | $11.58 | $12.82 | $7.1896 | +36.71% |
| August, 2028 | $6.6214 | $8.3314 | $6.4884 | -21.83% |
| September, 2028 | $6.1732 | $9.6946 | $8.9623 | -27.12% |
| October, 2028 | $2.548 | $5.008 | $4.732 | -69.92% |
| November, 2028 | $5.4298 | $5.3839 | $4.2798 | -35.89% |
| December, 2028 | $7.6816 | $7.4028 | $6.9097 | -9.31% |
Arcutis Biotherapeutics Inc Stock (ARQT) Price Forecast for 2029
The 2029 price forecast for Arcutis Biotherapeutics Inc Stock (ARQT) is $6.002 on average, with a high prediction of $12.00 and a low estimate of $0.000988. This represents an -29.14% decrease from the previous price of $8.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $9.6664 | $7.9446 | $7.5155 | +14.13% |
| February, 2029 | $9.2182 | $7.4153 | $6.4223 | +8.83% |
| March, 2029 | $14.11 | $9.2012 | $8.5701 | +66.59% |
| April, 2029 | $4.0948 | $5.2548 | $12.00 | -51.65% |
| May, 2029 | $0.9967 | $2.3237 | $3.3078 | -88.23% |
| June, 2029 | $3.2085 | $2.5396 | $0.9515 | -62.12% |
| July, 2029 | $4.8867 | $2.2756 | $8.9127 | -42.31% |
| August, 2029 | $0.5651 | $0.0262 | $6.7581 | -93.33% |
| September, 2029 | $0.5869 | $0.000988 | $1.879 | -93.07% |
| October, 2029 | $2.0217 | $0.2872 | $8.6372 | -76.13% |
| November, 2029 | $0.5665 | $0.1834 | $2.5865 | -93.31% |
| December, 2029 | $0.4483 | $0.6065 | $1.4017 | -94.71% |
Arcutis Biotherapeutics Inc Stock (ARQT) Price Forecast for 2030
Arcutis Biotherapeutics Inc Stock (ARQT) is expected to reach an average price of $3.1978 in 2030, with a high forecast of $6.1329 and a low forecast of $0.2628. This signifies an -62.25% decrease from the last price of $8.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.9801 | $1.9012 | $2.9701 | -41.20% |
| February, 2030 | $3.2219 | $4.229 | $4.7131 | -61.96% |
| March, 2030 | $0.3137 | $2.0337 | $1.9399 | -96.30% |
| April, 2030 | $2.3735 | $0.9067 | $1.7403 | -71.98% |
| May, 2030 | $6.2903 | $2.3844 | $4.7053 | -25.73% |
| June, 2030 | $5.3022 | $7.5133 | $5.8663 | -37.40% |
| July, 2030 | $6.237 | $2.3894 | $4.242 | -26.36% |
| August, 2030 | $5.5788 | $6.2738 | $6.1329 | -34.13% |
| September, 2030 | $3.4636 | $3.6576 | $3.9017 | -59.11% |
| October, 2030 | $0.6146 | $0.4454 | $2.4665 | -92.74% |
| November, 2030 | $1.0528 | $0.2628 | $2.7387 | -87.57% |
| December, 2030 | $2.478 | $0.349 | $4.051 | -70.74% |
1.53%
3.38%
Cap:
|
Volume (24h):